Brief: Onesource Specialty Pharma Says Unit 2 Granted GMP Certification By Anvisa
10/04/2025 09:34
April 10 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: ONESOURCE SPECIALTY PHARMA LTD - UNIT 2 GRANTED GMP CERTIFICATION BY ANVISA ONESOURCE SPECIALTY PHARMA LTD - CERTIFICATION FOLLOWS SUCCESSFUL REGULATORY INSPECTION IN NOVEMBER 2024 ONESOURCE SPECIALTY PHARMA LTD - APPROVAL ENABLES SUPPLY OF DDCS AND GLP-1S TO BRAZILIAN MARKET Source text: ID:nBSE2XzrqQ Further company coverage: ONEO.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsBrief: Onesource Specialty Pharma Not To Pursue Merger Of Facilities Of Steriscienceat With Co
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia